DOCSLIB.ORG

Sildenafil Reverses O2 Constriction of the Rabbit Ductus Arteriosus by Inhibiting Type 5 Phosphodiesterase and Activating Bkca C

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sildenafil Reverses O2 Constriction of the Rabbit Ductus Arteriosus by Inhibiting Type 5 Phosphodiesterase and Activating Bkca C 0031-3998/02/5201-0019 PEDIATRIC RESEARCH Vol. 52, No. 1, 2002 Copyright © 2002 International Pediatric Research Foundation, Inc. Printed in U.S.A. Sildenafil Reverses O2 Constriction of the Rabbit Ductus Arteriosus by Inhibiting Type 5 Phosphodiesterase and Activating BKCa Channels BERNARD THÉBAUD, EVANGELOS MICHELAKIS, XI-CHEN WU, GWYNETH HARRY, KYOKO HASHIMOTO, AND STEPHEN L. ARCHER Department of Medicine (Cardiology) and the Vascular Biology Group [B.T., E.M., X.-C.W., G.H., K.H., S.L.A.], Department of Physiology [S.L.A.], University of Alberta, Edmonton, Alberta, T6G 2S2, Canada ABSTRACT Oxygen constriction causes functional closure of the ductus the DA by increasing soluble guanylyl-cyclase–derived cGMP arteriosus (DA) at birth. Although DA closure is crucial for levels and thereby activating calcium-sensitive potassium chan- postnatal adaptation, patency of the DA is critical for survival of nels, causing membrane hyperpolarization. Sildenafil, already newborns with duct-dependent cardiac malformations. In these approved for human usage, might be an alternative or a useful cases, DA patency is achieved by i.v. infusion of prostaglandin adjunct to prostaglandin E1 as a bridge to cardiac surgery. E1, which, though effective, is often associated with complica- (Pediatr Res 52: 19–24, 2002) tions. We hypothesized that sildenafil, a specific phosphodiester- ase type 5 inhibitor, is an effective DA vasodilator. In isolated Abbreviations DA rings from term (d 30) fetal rabbits, sildenafil (10Ϫ6–10Ϫ4 4-AP, 4-aminopyridine Ϫ7 Ϫ5 M) and diethylamine NONOate (10 –10 M) induced dose- BKCa, large conductance calcium-sensitive potassium channels dependent relaxation of oxygen-constricted DA (Ϫ52 Ϯ 4% and cGMP, 3',5'-cyclic GMP Ϫ51 Ϯ 6%, respectively) that was inhibited by the soluble DA, ductus arteriosus guanylyl-cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxa- DASMC, DA smooth muscle cells lin-1-one (5 ϫ 10Ϫ5 M). Sildenafil increased cyclic GMP levels. DEANO, diethylamine NONOate Iberiotoxin (200 nM), an inhibitor of calcium-sensitive potas- Em, membrane potential sium channels, decreased the vasodilatory effect of sildenafil and IBTX, iberiotoxin diethylamine NONOate (Ϫ30 Ϯ 2% and Ϫ27 Ϯ 4%, respective- IK, whole-cell potassium current ly). Oxygen inhibition of whole-cell Kϩ current and membrane NO, nitric oxide depolarization were partially restored by sildenafil, and this was O2, oxygen inhibited by iberiotoxin. Immunohistochemistry and immuno- ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one blotting confirmed the presence of phosphodiesterase type 5 and PDE-5, type 5 phosphodiesterase calcium-sensitive potassium channels in the DA smooth muscle PG, prostaglandin cells. This is the first study to demonstrate that sildenafil dilates sGC, soluble guanylate cyclase The DA is a vital fetal structure that connects the pulmonary tation, is initiated by an increase in O2. In full-term newborns, artery to the descending aorta. During fetal life, the DA shunts the DA closes 24–48 h after delivery (1). However, in new- over half of the blood flow away from the lung into the borns with duct-dependent cyanotic cardiac malformations umbilico-placental circulation, where gas exchange takes place (e.g. transposition of the great vessels) or duct-dependent aortic (1). At birth, closure of the DA, essential for postnatal adap- obstructions (including hypoplastic left heart syndrome and coarctation of the aorta), patency of the DA is critical for survival until surgery. The paramount importance of PG in the Received December 21, 2001; accepted March 1, 2002. regulation of ductal tone is well established [reviewed in (2)]. Correspondence: Stephen Archer, M.D., Cardiology, University of Alberta, 2C2.36 Walter Mackenzie Health Sciences Center, Edmonton, AB, Canada T6G 2B7; e-mail: This has resulted in successful pharmacological manipulation [email protected] of the DA (3). To date, PGE1 is the only available therapy to B.T. is supported by the Canadian Institutes for Health Research, and by the Alberta Heritage Foundation for Medical Research, a grant from the French Ministry for Foreign maintain DA patency (4). Although effective, numerous side Affairs, the Fondation pour la Recherche Médicale and the Société Française de Médecine effects are associated with PGE1 infusions (respiratory depres- Périnatale. E.M. and S.L.A. are both supported by the Alberta Heritage Foundation for sion, fever, lethargy, irritability, myoclonic jerks, flushing, Medical Research, the Canadian Institutes for Health Research, the Heart and Stroke Foundation of Canada, and the Canadian Foundation for Innovation. edema, pyloric stenosis, hyperostosis, necrotizing enterocolitis, 19 20 THÉBAUD ET AL. and structural remodeling of the DA and the pulmonary ves- potential of Ϫ70 mV and currents were evoked by steps of 200 sels) (5, 6). The reported incidence of this host of complica- ms duration from Ϫ70 to ϩ70 mV. tions ranges from 10 to 40%. To determine the effect of sildenafil on IK and Em, hypoxic Ϫ5 Although PGs are major endogenous regulators of DA tone, DASMC were successively exposed to O2 and sildenafil (10 endothelium-derived NO also modulates DA tone (7, 8). NO M). To characterize the type of current activated by sildenafil, activates smooth muscle sGC, which increases intracellular the DASMC were exposed to 4-AP (5 mM) and then IBTX cGMP levels, causing vasodilatation. cGMP in turn, is rapidly (100 nM). In additional experiments, the effects of sildenafilon degraded by the cGMP-specific PDE-5. Basal stimulation of Em in normoxic DASMC were recorded after exposure to sGC and increased smooth muscle cGMP levels contribute to IBTX or 4-AP. DA relaxation (9, 10). Consequently, we hypothesized that Immunoblotting. Immunoblots were performed on fresh inhibition of cGMP breakdown might be efficacious in achiev- hypoxic DA using a panel of protease inhibitors, as previously ing dilatation of the DA. Sildenafil, readily available orally and described (15). Antibodies were obtained from Calbiochem widely used in the treatment of erectile dysfunction (11), is a (San Diego, CA, U.S.A.; PDE-5) and Alomone Lab (Jerusa- potent vasodilator that enhances and prolongs the action of lem, Israel; BKCa). cGMP by selectively inhibiting PDE-5. Furthermore, cGMP Immunohistochemistry. Immunohistochemistry was per- induces vasodilatation, in large part, by activating protein formed on paraffin-embedded, formaldehyde-fixed DA, as pre- kinase G and thereby opening BKCa, causing membrane hy- viously described (15). After overnight incubation with pri- perpolarization (12, 13). Therefore, we assessed the efficacy mary antibody (4°C), slides were incubated for 20 min with the and mechanism of action of sildenafilinO2-constricted, term secondary antibody, either biotinylated anti-Rabbit IgG (for rabbit DA. PDE-5 and BKCa protein) or anti-Mouse IgG [for endothelial nitric-oxide synthase (eNOS) protein] (Vector Laboratories, METHODS Burlingame, CA, U.S.A.) each at 1/200 dilution. The signal was revealed using a Chromagen (DAB) kit (Biogenex, San All procedures were approved by the Animal Health Care Ramon, CA, U.S.A.). In all cases, the secondary antibody Committee of the University of Alberta. Fetal New Zealand created reddish-brown staining. Antibodies for PDE-5 (1/1000) White rabbits were delivered by cesarean section at 30 d of and BKCa (1/100) were the same as for the immunoblotting. gestation (term ϭ 31 d) and killed with an i.p. overdose of Antibodies for eNOS were obtained from BD Transduction pentobarbital. The DA was excised under a dissecting micro- Lab (Oakville, ON, Canada). scope and used within 5 min in the following studies. Statistics and drugs. Values are expressed as mean Ϯ SEM. Isolated DA rings. The isolated DA was placed in an organ Intergroup comparisons were performed with a t test or a bath and studied in Krebs solution containing meclofenamate factorial, repeated-measures ANOVA, as appropriate. Fisher’s (10Ϫ5 M), as previously described (14). After 1 h equilibration probable least significant differences test was used for post hoc ϭ Ϯ Ͻ in hypoxia (PO2 31 1 mm Hg, a level similar to that in comparisons. A p value of 0.05 was considered to be ϭ utero), the DA was exposed to a normoxic solution (PO2 127 statistically significant. All drugs, except sildenafil, a generous Ϯ 1 mm Hg) and the vasodilatory effect of sildenafil (10Ϫ6– gift from Pfizer Pharmaceuticals (Sandwich, England), were 10Ϫ4 M), the NO donor DEANO (10Ϫ7–10Ϫ5 M), and PGE1 purchased from Sigma Chemical (St. Louis, MO, U.S.A.). (10Ϫ12–10Ϫ9 M) were compared by administering each agent Sildenafil, ODQ, and IBTX were dissolved in DMSO. PGE1 at the peak of O2 constriction. To further assess the mechanism was dissolved in ethanol. DEANO was dissolved in water of sildenafil-induced DA dilatation, we compared the vasodi- immediately before use and kept refrigerated. latory effect of these drugs after preincubation of the DA with ϫ Ϫ5 the sGC inhibitor, ODQ (5 10 M), or the specificBKCa RESULTS channel blocker IBTX (200 nM). In additional experiments, we studied the effects of preincubation with vehicle, sildenafil Sildenafil relaxes O2-constricted DA. In O2-constricted DA, Ϫ4 ϫ Ϫ5 ϩ (10 M), ODQ (5 10 M), or sildenafil ODQ on O2 sildenafil, DEANO, and PGE1 induce cumulative, dose- constriction. Relaxation was expressed as percentage relax- dependent, relaxations (Ϫ52 Ϯ 4%, Ϫ51 Ϯ 6%, and Ϫ73 Ϯ ation of the active tone. 4%, respectively, Fig. 1, A–C). Treatment of DA rings with Ϫ4 cGMP levels. To assess whether sildenafil causes relaxation sildenafil (10 M) before exposure to O2 also attenuates by increasing cGMP levels in the DA, we determined cGMP O2-induced constriction (Fig. 1D). levels in the Krebs solution taken from the ring bath under sGC inhibition reduces sildenafil-induced relaxation and hypoxia and normoxia in the following conditions: after pre- cGMP accumulation. ODQ (5 ϫ 10Ϫ5 M) significantly re- incubation of the DA with vehicle, sildenafil (10Ϫ4 M), or duces sildenafil- and DEANO-induced relaxation but not PGE1 sildenafil ϩ ODQ (5 ϫ 10Ϫ5 M).
Load more

Recommended publications
  • A Biochemical Rationale for the Discrete Behavior of Nitroxyl and Nitric Oxide in the Cardiovascular System
    A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system Katrina M. Miranda*†‡, Nazareno Paolocci§, Tatsuo Katori§, Douglas D. Thomas*, Eleonora Ford¶, Michael D. Bartbergerʈ, Michael G. Espey*, David A. Kass§, Martin Feelisch**, Jon M. Fukuto¶, and David A. Wink*† *Radiation Biology Branch, Building 10, Room B3-B69, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; §Division of Cardiology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD 21287; ¶Department of Molecular and Medical Pharmacology, Center for the Health Sciences, University of California, Los Angeles, CA 90095; ʈDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095; and **Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA 71130 Edited by Louis J. Ignarro, University of California School of Medicine, Los Angeles, CA, and approved May 20, 2003 (received for review February 20, 2003) The redox siblings nitroxyl (HNO) and nitric oxide (NO) have often cellular thiol functions (14, 15). Conversely, NO reacts only indi- been assumed to undergo casual redox reactions in biological sys- rectly with thiols after RNOS formation (17). tems. However, several recent studies have demonstrated distinct Contrasting effects are also apparent in vivo or ex vivo,for pharmacological effects for donors of these two species. Here, infu- example in models of ischemia reperfusion injury. Exposure to NO sion of the HNO donor Angeli’s salt into normal dogs resulted in donors at the onset of reperfusion provides protection against elevated plasma levels of calcitonin gene-related peptide, whereas reperfusion injury in the heart and other organs (18–20).
    [Show full text]
  • Download Product Insert (PDF)
    Product Information DEA NONOate Item No. 82100 CAS Registry No.: 372965-00-9 Formal Name: Diethylammonium (Z)-1-(N,N- diethylamino)diazen-1-ium-1,2-diolate O Synonyms: DEA/NO, Diethylamine NONOate N MF: C4H10N3O2 • C4H12N + N N • H N FW: 206.3 2 Purity: ≥98% O- Stability: ≥1 year at -80°C Supplied as: A crystalline solid l UV/Vis.: max: 250 nm Laboratory Procedures For long term storage, keep DEA NONOate sealed under nitrogen at -80°C. It should be stable for at least one year. The crystals are sensitive to moisture and become discolored on exposure to air. Keep the vial sealed until use unless your laboratory is equipped with a glove box with an inert atmosphere for the handling of air sensitive compounds. DEA NONOate is supplied as a crystalline solid. A stock solution may be made by dissolving the DEA NONOate in an organic solvent purged with an inert gas. DEA NONOate is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide (DMF). The solubility of DEA NONOate is approximately 25 mg/ml in ethanol and 2 mg/ml in DMSO and DMF. Further dilutions of the stock solution into aqueous buffers or isotonic saline should be made prior to performing biological experiments. Ensure that the residual amount of organic solvent is insignificant, since organic solvents may have physiological effects at low concentrations. Organic solvent-free aqueous solutions of DEA NONOate can be prepared by directly dissolving the crystalline compound in aqueous buffers. The solubility of DEA NONOate in PBS (pH 7.2) is approximately 10 mg/ml.
    [Show full text]
  • S100P Interacts with P53 While Pentamidine Inhibits This Interaction
    biomolecules Article S100P Interacts with p53 while Pentamidine Inhibits This Interaction Revansiddha H. Katte 1 , Deepu Dowarha 1 , Ruey-Hwang Chou 2,3 and Chin Yu 1,* 1 Department of Chemistry, National Tsing Hua University, Hsinchu 30013, Taiwan; [email protected] (R.H.K.); [email protected] (D.D.) 2 Graduate Institute of Biomedical Sciences and Center for Molecular Medicine, China Medical University, Taichung 40402, Taiwan; [email protected] 3 Department of Biotechnology, Asia University, Taichung 41354, Taiwan * Correspondence: [email protected]; Tel.: +886-963-780-784; Fax: +886-35-711082 Abstract: S100P, a small calcium-binding protein, associates with the p53 protein with micromolar affinity. It has been hypothesized that the oncogenic function of S100P may involve binding-induced inactivation of p53. We used 1H-15N HSQC experiments and molecular modeling to study the molecular interactions between S100P and p53 in the presence and absence of pentamidine. Our experimental analysis indicates that the S100P-53 complex formation is successfully disrupted by pentamidine, since S100P shares the same binding site for p53 and pentamidine. In addition, we showed that pentamidine treatment of ZR-75-1 breast cancer cells resulted in reduced proliferation and increased p53 and p21 protein levels, indicating that pentamidine is an effective antagonist that interferes with the S100P-p53 interaction, leading to re-activation of the p53-21 pathway and inhibition of cancer cell proliferation. Collectively, our findings suggest that blocking the association between S100P and p53 by pentamidine will prevent cancer progression and, therefore, provide a new avenue for cancer therapy by targeting the S100P-p53 interaction.
    [Show full text]
  • Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
    Review Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics Joel Mintz 1,†, Anastasia Vedenko 2,†, Omar Rosete 3 , Khushi Shah 4, Gabriella Goldstein 5 , Joshua M. Hare 2,6,7 , Ranjith Ramasamy 3,6,* and Himanshu Arora 2,3,6,* 1 Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, FL 33328, USA; [email protected] 2 John P Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA; [email protected] (A.V.); [email protected] (J.M.H.) 3 Department of Urology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA; [email protected] 4 College of Arts and Sciences, University of Miami, Miami, FL 33146, USA; [email protected] 5 College of Health Professions and Sciences, University of Central Florida, Orlando, FL 32816, USA; [email protected] 6 The Interdisciplinary Stem Cell Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA 7 Department of Medicine, Cardiology Division, Miller School of Medicine, University of Miami, Miami, FL 33136, USA * Correspondence: [email protected] (R.R.); [email protected] (H.A.) † These authors contributed equally to this work. Abstract: Nitric oxide (NO) is a short-lived, ubiquitous signaling molecule that affects numerous critical functions in the body. There are markedly conflicting findings in the literature regarding the bimodal effects of NO in carcinogenesis and tumor progression, which has important consequences for treatment. Several preclinical and clinical studies have suggested that both pro- and antitumori- Citation: Mintz, J.; Vedenko, A.; genic effects of NO depend on multiple aspects, including, but not limited to, tissue of generation, the Rosete, O.; Shah, K.; Goldstein, G.; level of production, the oxidative/reductive (redox) environment in which this radical is generated, Hare, J.M; Ramasamy, R.; Arora, H.
    [Show full text]
  • Nitric Oxide Attenuates Hypoxia-Induced 5-FU Resistance
    Sasabe et al. Int J Cancer Clin Res 2015, 2:2 DOI: 10.23937/2378-3419/2/2/1014 International Journal of Cancer and Clinical Research ISSN: 2378-3419 Original Article: Open Access Nitric Oxide Attenuates Hypoxia-Induced 5-FU Resistance of Oral Squamous Cell Carcinoma Cells Eri Sasabe*, Ayumi Tomomura, Mayuko Hamada, Naoya Kitamura, Tomohiro Yamada and Tetsuya Yamamoto Department of Oral and Maxillofacial Surgery, Kochi Medical School, Kochi University Kohasu, Japan *Corresponding author: Eri Sasabe, Department of Oral and Maxillofacial Surgery, Kochi Medical School, Kochi University Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan, Tel: +81-88-880-2423, Fax: +81-88-880-2424, E-mail: [email protected] to development and progression of malignancies, and resistance Abstract to cancer therapy. The heterodimeric transcription factor Hypoxia Hypoxic environments in tumors induce expression of hypoxia- inducible factor (HIF) is a master regulator that can adapt tumor cells inducible factor (HIF). HIF contributes to the development of the to hypoxic conditions [1]. Overexpression of HIF has been observed malignant progression through the induction of various target genes. in many different cancers, including head and neck squamous cell We previously reported that treatment with chemotherapeutic drugs and γ-rays enhances expression and nuclear translocation carcinomas, and is associated with increased patient mortality [2-4]. of HIF-1α under normoxic conditions; susceptibility of oral HIF consists of an oxygen-regulated α-subunit and a constitutively squamous cell carcinoma (OSCC) cells to the drugs and γ-rays expressed β-subunit, also known as aryl hydrocarbon receptor is negatively correlated with expression of HIF-1α protein.
    [Show full text]
  • Oxidative Stress and the Guanosine Nucleotide Triphosphate Pool: Implications for a Biomarker and Mechanism of Impaired Cell Function
    University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 2008 OXIDATIVE STRESS AND THE GUANOSINE NUCLEOTIDE TRIPHOSPHATE POOL: IMPLICATIONS FOR A BIOMARKER AND MECHANISM OF IMPAIRED CELL FUNCTION Celeste Maree Bolin The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Bolin, Celeste Maree, "OXIDATIVE STRESS AND THE GUANOSINE NUCLEOTIDE TRIPHOSPHATE POOL: IMPLICATIONS FOR A BIOMARKER AND MECHANISM OF IMPAIRED CELL FUNCTION" (2008). Graduate Student Theses, Dissertations, & Professional Papers. 728. https://scholarworks.umt.edu/etd/728 This Dissertation is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. OXIDATIVE STRESS AND THE GUANOSINE NUCLEOTIDE TRIPHOSPHATE POOL: IMPLICATIONS FOR A BIOMARKER AND MECHANISM OF IMPAIRED CELL FUNCTION By Celeste Maree Bolin B.A. Chemistry, Whitman College, Walla Walla, WA 2001 Dissertation presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Toxicology The University of Montana Missoula, Montana Spring 2008 Approved by: Dr. David A. Strobel, Dean Graduate School Dr. Fernando Cardozo-Pelaez,
    [Show full text]
  • Sustained Formation of Nitroglycerin-Derived Nitric Oxide
    Supplemental material to this article can be found at: http://molpharm.aspetjournals.org/content/suppl/2018/01/22/mol.117.110783.DC1 1521-0111/93/4/335–343$35.00 https://doi.org/10.1124/mol.117.110783 MOLECULAR PHARMACOLOGY Mol Pharmacol 93:335–343, April 2018 Copyright ª 2018 The Author(s). This is an open access article distributed under the CC BY Attribution 4.0 International license. Sustained Formation of Nitroglycerin-Derived Nitric Oxide by Aldehyde Dehydrogenase-2 in Vascular Smooth Muscle without Added Reductants: Implications for the Development of Nitrate Tolerance s Marissa Opelt, Gerald Wölkart, Emrah Eroglu, Markus Waldeck-Weiermair, Roland Malli, Wolfgang F. Graier, Alexander Kollau, John T. Fassett, Astrid Schrammel, Bernd Mayer, and Antonius C. F. Gorren Downloaded from Institute of Pharmaceutical Sciences, Department of Pharmacology and Toxicology, Karl-Franzens University (M.O., G.W., A.K., J.T.F., A.S., B.M., A.C.F.G.), and Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University Graz (E.E., M.W.-W., R.M., W.F.G.), Graz, Austria Received October 4, 2017; accepted January 18, 2018 molpharm.aspetjournals.org ABSTRACT According to current views, oxidation of aldehyde dehydrogenase-2 ALDH2, thiol-refractive inactivation was observed, particularly under (ALDH2) during glyceryltrinitrate (GTN) biotransformation is essen- high-turnover conditions. Organ bath experiments with rat aortas tially involved in vascular nitrate tolerance and explains the de- showed that relaxation by GTN lasted longer than that caused by the pendence of this reaction on added thiols. Using a novel fluorescent NO donor diethylamine/NONOate, in line with the long-lasting intracellular nitric oxide (NO) probe expressed in vascular smooth nanomolar NO generation from GTN observed in VSMCs.
    [Show full text]
  • New Insights Into the Role of Soluble Guanylate Cyclase in Blood Pressure Regulation
    New insights into the role of soluble guanylate cyclase in blood pressure regulation The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Buys, Emmanuel, and Patrick Sips. 2014. New Insights into the Role of Soluble Guanylate Cyclase in Blood Pressure Regulation. Current Opinion in Nephrology and Hypertension 23, no. 2: 135–142. doi:10.1097/01.mnh.0000441048.91041.3a. Published Version doi:10.1097/01.mnh.0000441048.91041.3a Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:29731915 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA NIH Public Access Author Manuscript Curr Opin Nephrol Hypertens. Author manuscript; available in PMC 2015 March 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Curr Opin Nephrol Hypertens. 2014 March ; 23(2): 135–142. doi:10.1097/01.mnh.0000441048.91041.3a. New Insights into the Role of Soluble Guanylate Cyclase in Blood Pressure Regulation Emmanuel Buys1 and Patrick Sips2 1Anesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA 2Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Abstract Purpose of review—Nitric oxide (NO) – soluble guanylate cyclase (sGC)-dependent signaling mechanisms have a profound effect on the regulation of blood pressure.
    [Show full text]
  • Nitric Oxide Lacks Direct Effect on TRPC5 Channels but Suppresses Endogenous TRPC5-Containing Channels in Endothelial Cells
    Pflugers Arch - Eur J Physiol (2010) 460:121–130 DOI 10.1007/s00424-010-0823-3 ION CHANNELS, RECEPTORS AND TRANSPORTERS Nitric oxide lacks direct effect on TRPC5 channels but suppresses endogenous TRPC5-containing channels in endothelial cells Ching-On Wong & Piruthivi Sukumar & David J. Beech & Xiaoqiang Yao Received: 25 November 2009 /Revised: 7 March 2010 /Accepted: 9 March 2010 /Published online: 14 April 2010 # Springer-Verlag 2010 Abstract TRPC5 is a member of the canonical transient (SNAP) and diethylamine NONOate (DEA-NONOate) receptor potential (TRPC) family of proteins that forms failed to stimulate or inhibit TRPC5 at concentrations that cationic channels either through homomultimeric assembly generated nitric oxide, caused vasorelaxation, or suppressed or heteromultimeric coordination with other TRPC proteins. activity of TRPC6 via protein kinase G. At high concen- It is expressed in a variety of cells including central neurones trations, SNAP (but not DEA-NONOate) occasionally and endothelial cells and has susceptibility to stimulation by stimulated TRPC5 but the effect was confounded by multiple factors. Here we investigated if TRPC5 is sensitive background TRPC5-independent Ca2+ signals. Endogenous to nitric oxide. Mouse TRPC5 or human TRPC5 was over- Ca2+-entry in bovine aortic endothelial cells (BAECs) was expressed in HEK293 cells, and TRPC5 activity was suppressed by SNAP; TRPC5 blocking antibody or determined by measuring the cytosolic Ca2+ concentration dominant-negative mutant TRPC5 suppressed this Ca2+ with an indicator dye or by recording membrane current entry and occluded the effect of SNAP. The data suggest under voltage clamp. TRPC5 activity could be evoked by that nitric oxide is not a direct modulator of homomeric carbachol acting at muscarinic receptors, lanthanum, or a TRPC5 channels but may inhibit endogenous BAEC reducing agent.
    [Show full text]
  • Role of Endothelium, Acetylocholine and Calcium Ions in Bay K8644- and Kcl-Induced Contraction
    914 MOLECULAR MEDICINE REPORTS 8: 914-918, 2013 Role of endothelium, acetylocholine and calcium ions in Bay K8644- and KCl-induced contraction KATARZYNA SZADUJKIS-SZADURSKA*, GRZEGORZ GRZESK*, LESZEK SZADUJKIS-SZADURSKI, MARTA GAJDUS, BARTOSZ MALINOWSKI and MICHAL WICINSKI Department of Pharmacology and Therapeutics, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz 85-094, Poland Received February 17, 2013; Accepted June 13, 2013 DOI: 10.3892/mmr.2013.1574 Abstract. The aim of this study was to establish the involve- the factors examined, resulting in an influx of Ca2+ into the ment of acetylcholine (Ach) and calcium ions in modulating cell. contractions induced by Bay K8644 (an agonist of calcium channels located in the cell membrane) and KCl (at depola- Introduction rizing concentrations), and also to examine the importance of the vascular endothelium in the activity of Bay K8644. The The structure of the arteries is important as serve as a target study was performed on perfused Wistar rat tail arteries. for a number of substances that regulate smooth muscle Contraction induced by Bay K8644 with the participation of tension. The endothelium is a cell layer that lines the inside intracellular (in calcium-free physiological salt solution, FPSS) of blood vessels, and also produces and releases mediators and extracellular (in physiological salt solution, PSS, following that modulate the contraction of arteries (1,2). the emptying of the cellular Ca2+ stores) pools of Ca2+ and the Endothelial damage occurs in the course of various path- addition of nitro-L-arginine (L-NNA; nitric oxide synthase ological processes, particularly atherosclerosis, and leads inhibitor) or 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one to vascular disorders with regard to diameter regulation, (ODQ; an inhibitor of soluble guanylyl cyclase) was studied.
    [Show full text]
  • Nitric Oxide/Cyclic Guanosine Monophosphate Pathway in the Peripheral and Central Auditory System of the Rat
    THE JOURNAL OF COMPARATIVE NEUROLOGY 404:52–63 (1999) Nitric Oxide/Cyclic Guanosine Monophosphate Pathway in the Peripheral and Central Auditory System of the Rat JAMES D. FESSENDEN,1 RICHARD A. ALTSCHULER,1 AUDREY F. SEASHOLTZ,2 AND JOCHEN SCHACHT1* 1Kresge Hearing Research Institute, University of Michigan, Ann Arbor, Michigan 48109–0506 2Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48109–0720 ABSTRACT The neuronal isoform of nitric oxide synthase (nNOS) and soluble guanylate cyclase (sGC) were localized in the cochlea, the cochlear nucleus (CN), and the superior olivary complex (SOC) of Fisher 344 rats. In the cochlea, nNOS was identified in spiral ganglion cells by using nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase histochemistry and in situ hybridization. NADPH-diaphorase staining also was detected in blood vessels of the modiolus. By using immunohistochemistry against cyclic guanosine monophosphate, cochlear sGC activity was localized to pericytes in the spiral ligament as well as nerve fibers innervating outer hair cells. In the lower auditory brainstem, nNOS was localized to principal cells of the medial nucleus of the trapezoid body (MNTB) with NADPH-diaphorase histochem- istry and in situ hybridization. NADPH-diaphorase activity also was observed in the lateral and medial superior olive (LSO and MSO, respectively), the superior periolivary nucleus (SPN), the ventral and lateral nuclei of the trapezoid body (VNTB and LNTB, respectively), and the ventral cochlear nucleus (VCN). Transcripts of the ␤-subunit of sGC were localized in rat brainstem by using in situ hybridization. mRNA for sGC was expressed in neurons within the SPN, LSO, MSO, LNTB, MNTB, VNTB, and VCN.
    [Show full text]
  • Specificity of Molecular Fragments Binding to S100B Versus S100A1
    molecules Article Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS) Brianna D. Young 1,2 , Wenbo Yu 2,3,4 , Darex J. Vera Rodríguez 1,2, Kristen M. Varney 1,2,4, Alexander D. MacKerell Jr. 2,3,4 and David J. Weber 1,2,4,* 1 Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene St., Baltimore, MD 21201, USA; [email protected] (B.D.Y.); [email protected] (D.J.V.R.); [email protected] (K.M.V.) 2 Center for Biomolecular Therapeutics (CBT), Baltimore, MD 21201, USA; [email protected] (W.Y.); [email protected] (A.D.M.J.) 3 Computer-Aided Drug Design Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA 4 Institute for Bioscience and Biotechnology Research (IBBR), Rockville, MD 20850, USA * Correspondence: [email protected]; Tel.: +01-410-706-4354 Abstract: S100B, a biomarker of malignant melanoma, interacts with the p53 protein and diminishes its tumor suppressor function, which makes this S100 family member a promising therapeutic target for treating malignant melanoma. However, it is a challenge to design inhibitors that are specific for S100B in melanoma versus other S100-family members that are important for normal cellular activi- ties. For example, S100A1 is most similar in sequence and structure to S100B, and this S100 protein is important for normal skeletal and cardiac muscle function. Therefore, a combination of NMR and Citation: Young, B.D.; Yu, W.; Rodríguez, D.J.V.; Varney, K.M.; computer aided drug design (CADD) was used to initiate the design of specific S100B inhibitors.
    [Show full text]